Background: It is debated whether a low total diversity of the gut microbiota in early 43
INTRODUCTION 87
It is debated whether low diversity of the gut microbiota in infancy is more important than the 88 prevalence of specific bacterial taxa when trying to explain why the prevalence of allergic 89 disease is increasing in affluent countries. Initially, several studies employing conventional 90 cultivation or fluorescent in situ hybridization (FISH) reported differences in the intestinal 91 microbiota at a species level between allergic and non-allergic children.
1-3 Allergic infants 92
were colonized less often with Bacteroides and bifidobacteria, 1, 2 more often with 93
Staphylococcus aureus, 2 and they had lower ratio of bifidobacteria to clostridia. 3 However, 94
there have been contradictory results in more recent studies. Two large European prospective 95 studies did not confirm any relationship with any particular bacterial group. 4, 5 96 97
As an alternative explanation, it has been suggested that low diversity of intestinal microbiota 98 would explain the increase of allergic disease in affluent societies. 6, 7 The underlying 99 rationale is that the gut immune system reacts to exposure to new bacterial antigens and 100 repeated exposure would enhance the development of immune regulation. Although this 101 theory emerged more than a decade ago, 8 there are still only few studies relating the diversity 102 with allergy, likely due to methodology limitations. In three studies employing molecular 103 techniques, terminal restriction fragment length polymorphism (T-RFLP) 6 and denaturating 104 gradient gel electrophoresis (DGGE) 9, 10 , infants developing sensitization 10 or eczema 6 9 105 were reported to have fewer peaks/bands than healthy ones. Yet, no specific microbes were 106 identified with these molecular methods. Furthermore, the sensitivity of the methods appears 107 to be low, since the median number of peaks/bands was much lower than the expected 108 number of bacterial species. possible to analyze the total microbiota down to the genus level, even in large cohorts. 14 In this study the infant received probiotics or placebo daily from day 126 1-3 until 12 months of age. Clinical follow-ups were done at 1, 3, 6, 12 and 24 months of age 127 and telephone interviews at 2, 4, 5, 8, 10 and 18 months. A questionnaire was completed on 128 each occasion. Stool samples were collected from the infants at age 5-7 days and at one 129 month and 12 months of age. The samples were immediately frozen at -20°C following 130 collection and later stored at -70°C. Among the 188 infants completing the original study and 131 from which stool samples were available from all three sampling occasions, 20 infants with 132 atopic eczema and 20 without any allergic manifestation were randomly selected to this study. 133
134
There were no differences regarding potential confounders such as sex, birth order, caesarean 135 section, family history of allergic disease, breastfeeding, antibiotics and probiotic 136 supplementation between the infants with and without atopic eczema (Table I) Also, reads lacking a correct primer and/or having less than 360 successful pyrosequencing 181 flows were removed.
17 Denoised sequences were trimmed to 198 bp after primer and barcode 182 removal and clustered by complete linkage clustering into operational taxonomic units 183 (OTUs) at the 97% similarity level using AmpliconNoise.
17 Each denoised sequence, as well 184 as the most abundant sequence for each OTU, was BLAST searched with default parameters 185 against a local BLAST database comprising 836.814 near full-length bacterial 16S rRNA 186 gene sequences from the Ribosomal Database Project (RDP) v. 10.10. 18 The sequences 187 inherited the taxonomic annotation (down to genus level) of the best scoring RDP hit 188 fulfilling the criteria of ≥ 95% identity over an alignment of length ≥ 180 bp. If no such hit 189 was found the sequence was classified as "no match". If multiple best hits were found and 190 these had conflicting taxonomies, the most detailed level of consensus taxonomy was 191 assigned to the OTU. Infants who developed atopic eczema, i.e. IgE-associated eczema, had a lower diversity of the 219 total microbiota and the bacterial phylum Bacteriodetes and its genus Bacteroides at one 220 month of age than infants who did not have any allergic manifestation during the two first 221 years of life (Table II) . The diversity of the phylum Proteobacteria, comprising Gram negative 222 bacteria, was also reduced in the atopic infants, significantly so at 12 months of age (Table  223 II). Furthermore, these phyla and genera differed significantly between atopic and non-atopic 224 infants with repeated-measures ANOVA including all sampling time points during the first 225 year of life (one month, one week and 12 months: p=0.049 for the total microbiota, p=0.04 for 226
Bacteroidetes, p= 0.02 for Bacteroides and p=0.02 for Proteobacteria). Probiotic 227 supplementation was a potential confounder. Even after exclusion of the probiotic-treated 228 infants, however, several significant differences and some statistical tendencies were still 229 observed. (p=0.03 for the total microbiota, p=0.06 for proteobacteria, p=0.096 for 230
Bacteroidetes, p= 0.03 for Bacteroides at 1 month, and p=0.06 for Proteobacteria and p=0.01 231 for Bacteroidetes and Bacteroides at 12 months, data not shown). Nine infants received 232 antibiotics between two and twelve months. Excluding them did not affect the result at 12 233 months (p=0.02 for Proteobacteria). 234
235
The relative abundance of the dominant bacterial phyla at various ages is displayed in Figure  236 1. During the first month of life there was a high inter-subject variability ( Figure E1 , online 237 repository) and no significant differences at the phylum level between infants who did and did 238 not develop atopic eczema. The relative abundance of Bacteroidetes, Proteobacteria and 239 Actinobacteria, the latter a phylum comprising bifidobacteria, which are associated with 240 breastfeeding, was high in both groups. At 12 months, however, these phyla had declined and 241
Firmicutes, comprising Gram positive aerobe and anaerobe bacteria, had become dominantresembling an adult microbiota pattern. At this age the relative abundance of Proteobacteria 243 was lower (Edge R test p=0.008, q=0.02) and Firmicutes tended to be higher (Edge R test 244 p=0.06, q=0.10) in atopic than non-atopic infants ( Table III especially during the first month of life. There was no significant difference between atopics 259 and non-atopics for any of the dominant bacterial genera, except for Enterococcus and 260
Peptostreptococcaceae Incertae Sedis, which were more abundant in atopic infants at 12 261 months of age. Among less abundant genera (relative abundance <1%), only a few differed 262 significantly between atopic and non-atopic infants after correcting for multiple testing. The 263 microaerophilic Gram negative Sutterella, belonging to the phylum Proteobacteria, was more 264 abundant in the non-atopic infants both at one and 12 months of age (healthy vs. Employing the new high-throughput 16S based molecular microbiology, we could confirm 279 and extend previous findings, that low intestinal diversity during the first month of life is 280 associated with an increased risk of subsequent atopic disease.
6 9 10 In contrast to previous 281 studies, we could also show that the differences in diversity and relative abundance were 282 attributed to specific bacterial phyla and genera, possibly because the sensitivity of our 283 analyses was higher than in previous diversity studies. 6, 9, 10 At 12 months, the mean of 284
OTUs/sample were 69 in our study, as compared to 8.5 bands/sample (in DGGE) in a recent 285 the study by Bisgaard et al. 10 It is noteworthy that the most important differences appeared 286 the first months of life, supporting the theory that factors influencing the early of maturation 287 of the immune system might be especially important for subsequent allergy development.
288
The study, however, did not clarify the debate whether a low total diversity of the gut 289 microbiota in early childhood is more important than altered prevalence of particular bacterial 290 species in allergy development. Total diversity was important, but the differences in diversity 291 and relative abundance seemed to be defined to specific bacteria. 292
293
The low diversity of the phylum Bacteroidetes and its genus Bacteroides in infants 294 developing atopic eczema is consistent with previous studies, reporting low levels of these 295 bacteria to be associated both with allergic disease 2 and factors associated with allergic 296 disease, such as a Western lifestyle 11, 12 and caesarean section. 3, 33 None of these bacteria were related to allergic disease in this study. 319
Neither was Clostridium a dominant bacterial genus. However, there were other genera within 320 the phylum Firmicutes that were more abundant in the atopic than the non-atopic infants. 321 Interestingly, Firmicutes have been associated to other conditions related to a westernized 322 lifestyle, such as obesity. 12, 34 323 Importantly, assessments of stool samples merely reflect luminal colonic microbiota and not 324 necessarily the colonization of the small intestine, in which the major part of the gut immune 325 system is situated. The higher oxygen content in the upper gut favors facultative bacteria such 326 as streptococci and lactobacilli, 35 which therefore might be more important than our results 327 indicate.
In conclusion, the results support the hypothesis that low microbial diversity early in life is 330 associated with an increased risk for allergic disease. 
